Category: Insights

The Nature of Asian Biopharmaceutical Innovation

Where are drugs invented, and how can easily innovation be seeded in new areas? DrugPatentWatch has published a paper on global biopharmaceutical productivity in the latest issue of Nature Biotechnology. This…
The post The Nature of Asian Biopharmaceut…


Where are drugs invented? Globalization in the pharmaceutical industry

Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch’s publications profiling the locations of pharmaceutical innovation. The location of…
The post Where are drugs invented? Globalization …


Pharmaceutical Investments: Making the Case for Better Intelligence

Market intelligence is especially critical to sound pharmaceutical investing Pharmaceutical investing is both challenging and potentially very rewarding, but it requires understanding trends in the industry, including which drugs are…
The post Pharmace…


A drug by any other name would work just as well — making sense of drug names

How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare’s play Romeo and Juliet, Juliet uses the phrase “A rose by any other name…
The post A drug by any other name would work just as well — making sen…


Biosimilar Naming: Distinguishable or Disingenuous?

This is a guest post from Robert Yapundich, MD and Gregory Schimizzi, MD. Dr. Yapundich is a practicing neurologist in Hickory, North Carolina and a member of the Alliance for…
The post Biosimilar Naming: Distinguishable or Disingenuous? appeared first…


Download FDA Orange Book Archives

How to Order the FDA Orange Book Historical copies of the FDA Orange Book archives are very potent tools for scholarly research and for litigation support, but until now there…
The post Download FDA Orange Book Archives appeared first on DrugPatentWatc…


Value-based drug pricing makes sense, but is difficult to pull off

Dana Goldman, Anupam Jena, Posted with permission from STAT It’s hard not to like the notion of value-based pricing for prescription drugs. It aims to ensure that the prices we pay for…
The post Value-based drug pricing makes sense, but is difficult to…


The Cost Of A Cure: Patent Rights And Drug Prices

One of the hottest-button political issues of the day is high prescription drug costs. On one side of the debate are politicians and patient groups espousing a populist viewpoint seeking…
The post The Cost Of A Cure: Patent Rights And Drug Prices appea…


How a $37,000-a-year medicine sets a good model for drug pricing

Ed Silverman, Posted with permission from STAT Shortly before his company won the right last week to sell a new drug for severe eczema, Dr. Len Schleifer made a brash…
The post How a $37,000-a-year medicine sets a good model for drug pricing appeared f…


Q&A: Three big mistakes drug companies make in recruiting new employees

Rebecca Robbins, Posted with permission from STAT Plus When drug and device makers need a new chief medical officer or vice president, they often start by turning to executive recruiters. One…
The post Q&A: Three big mistakes drug companies make in rec…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: